Navigation Links
ADVENTRX Announces Appointment Of Chief Medical Officer
Date:8/14/2012

from the University of Maryland and completed a residency in internal medicine at the Baylor College of Medicine. 

"I have been closely involved in the development and lifecycle management of several transformative products, including Lovenox®, Cubicin®, Xarelto®, and Natrecor®, and I look forward to playing a key role in successful development of ANX-188, which has the potential to treat many serious and life-threatening diseases and conditions," said Dr. Vetticaden. "With the phase 3 study in sickle cell disease anticipated to begin this year, joining ADVENTRX is an opportunity to have a potentially transformational impact in the treatment of diseases and conditions associated with microvascular dysfunction."

"Dr. Vetticaden brings to ADVENTRX decades of drug development and clinical experience as well as valuable clinical pharmacology and translational expertise," stated Brian M. Culley, Chief Executive Officer of ADVENTRX. "He has a proven track record of advancing innovative therapies through all stages of the product lifecycle and is a welcome addition to our senior management team as we advance ANX-188 into a phase 3 study."

About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions. The Company's lead product candidate, ANX-188, has potential to reduce ischemic tissue injury and end-organ damage by restoring microvascular function which is compromised  in a wide range of serious and life-threatening diseases and conditions.  The Company initially is developing ANX-188 as a treatment for complications arising from sickle cell disease. More information can be found on the Company's web site at www.adventrx.com.

Forward Looking Statements
ADVENTRX cautions you that statements included in this press release that are not a description of histo
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
2. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
3. ADVENTRX Pharmaceuticals To Present At The OneMedForum New York 2012 Emerging Company Finance Conference On July 12
4. ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product
5. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
6. FDAnews Announces Medical Device Mobile Apps Virtual Conference
7. Dehaier Medical Announces 2012 Second Quarter and Six Month Financial Results
8. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
11. Comprehensive Care Corporation Announces Profitable Six Month Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... W. Robin , is scheduled to present at the ... York at the Sheraton New York Hotel on ... The presentation will be accessible via a Webcast through ... of the Nektar website: http://www.nektar.com . This Webcast will ...
(Date:5/16/2013)... FRAMINGHAM, Mass. and SYDNEY , ... HTWR - ASX: HIN), a leading innovator of less ... of advanced heart failure, today announced that CEO ... 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on ... 20-22, 2013 at the Sheraton New York Hotel. ...
(Date:5/16/2013)... 16, 2013  Amgen (NASDAQ: AMGN ) will ... May 21, 2013, at the Sheraton New York Times Square ... 10:00 a.m. Eastern Daylight Time. Joseph P. Miletich ... Development at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
Breaking Medicine Technology:Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... BALTIMORE, Sept. 12, 2011 CSA Medical, Inc. ( ... devices that flash freeze and treat diseased tissue inside ... to the newly created position of Vice President, Emerging ... responsible for the development of new therapeutic applications for ...
... 12, 2011 Breast Imaging facilities looking ... benefit from the exceptional image quality of the Aspire™ ... Medical Systems U.S.A., Inc. Now FDA 510(k) cleared, the ... of potential abnormalities that not only assists in more ...
Cached Medicine Technology:CSA Medical Appoints Wendelin Maners VP of Emerging Therapies 2Fujifilm's Aspire HD Receives FDA Clearance 2Fujifilm's Aspire HD Receives FDA Clearance 3
(Date:5/18/2013)... 6Webs.com is the leader in ... and comprehensive comparisons make 6Webs.com the useful resource consumers ... just recently finished conducting their assessments of the leading ... from 6Webs.com reports, "There has been an increase interest ... of use, expandability and mobility. Combine these features with ...
(Date:5/18/2013)... Houston, TX (PRWEB) May 18, 2013 Show ... many years of various different training systems that is all ... possible has caught the attention of http://ShowAndGoTrainingReview.com ’s ... Go Training is a unique “four phase system” designed ... the minimum amount of time spent working out in the ...
(Date:5/18/2013)... 2013 The California College of Ayurveda ... the Ayurvedic Spa , the client receives stress ... and lifestyle recommendations and stress management techniques by ... is the traditional healthcare system of India. It is ... is the basis for all optimum health. Ayurveda believes ...
(Date:5/18/2013)... 18, 2013 The American Society ... A. Kitzhaber, M.D., (D) to sign a bill (HB ... minors under the age of 18 from tanning indoors. ... third state in the nation to enact an under-18 ... indoor tanning bans for minors. Nationwide, 34 states and ...
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental laser ... of the root causes of sleep apnea to provide and ... Sleep Month, Dr. Tracey points out estimates revealing that 40 ... sleep apnea is one of the most common of all. ... breathing at different times while sleeping. When this happens, the ...
Breaking Medicine News(10 mins):Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3
... whether people were scanned or not , , FRIDAY, Feb. 6 ... low back pain that has no apparent underlying cause doesn,t ... that doctors should not conduct routine MRI, CT or radiography ... authors say. , Dr. Roger Chou, of the Oregon Health ...
... for Palliative Medicine,s Fellowship Program received full accreditation from ... the first accredited fellowship program in palliative medicine in ... Hospice, The Institute for Palliative Medicine has trained fellows ... is known as one of the most clinically demanding ...
... Scientists at Melbourne,s Burnet Institute have developed a potential ... which described the invention, has recently been published in ... Investigation . , Head of the Burnet Institute,s ... his group has produced a monoclonal antibody to a ...
... This release is available in Spanish . ... fundamental role in the prognosis of acute lymphoblastic leukemia as ... of research involving a team made up of specialists from ... Medical Research at the same University of Navarra, as well ...
... Deal Reflects Steady Progress in Expanding Reach Across ... Food IndustryMUNDELEIN, Ill., Feb. 6 Z Trim ... multi-functional food ingredients, has agreed to an exclusive ... a company engaged in the supply of various ...
... 6 Abbott ( NYSE: ABT ),today announced that ... 1976 (HSR) applicable to Abbott,s cash tender offer to,purchase ... Advanced Medical,Optics (AMO) expired last night at 11:59 p.m. ... of the HSR waiting period satisfies one of the ...
Cached Medicine News:Health News:Imaging of Low Back Pain Fails to Change Outcomes 2Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 2Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 3Health News:New treatment hope for prostate cancer 2Health News:New genes involved in acute lymphoblastic leukemia play fundamental role in prognosis of the disease 2Health News:Z Trim to be Distributed in Israel by Freya ICB 2Health News:Z Trim to be Distributed in Israel by Freya ICB 3Health News:Z Trim to be Distributed in Israel by Freya ICB 4Health News:Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review 2Health News:Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review 3
... TowerPack is an innovative, quick and ... Tips. Use 60% less space on ... plastic. With this amazingly easy-to-use, one-hand ... for the whole range of Diamond ...
10 L, Racked, 96 tips/rack Extended length pipette tips recommended for 5 and 10 L pipettes....
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 ul reference mark make it ideal for low volume pipetting....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
Medicine Products: